Coronavirus

Opt-in "Exposure Notifications" are included in new operating system updates on both companies' platforms and available now to worldwide public health agencies.

The consumer-facing digital platform for health testing was forced to pump the brakes on a similar offering roughly two months ago.

Getting defibrillators to cardiac arrest patients as quickly as possible is a priority for emergency services everywhere. In one area of Sweden, 112 call takers will soon be able to dispatch a drone at the same time as an ambulance to drop a defibrillator near the patient if they suspect a cardiac arrest.

Fitbit's CEO James Park told CNBC that the company will be submitting its technology to the FDA soon. 

The new tech is designed to help curb face-to-face interactions during the coronavirus pandemic. 

The tests give users the option to share information to aid national research into the virus.

The HIMSS Media team discusses how vendors, payers and policymakers are looking to answer the growing demand for mental and behavioral health services.

A bipartisan quartet of lawmakers wrote to Congressional leaders on the need to deliver additional funds through the longstanding Rural Health Care Program.

The companies will join forces and create a new app called My Next Health, which helps gauge risk for certain conditions, including the coronavirus. 

Following a virtual consultation, both companies are supplying Rutgers Clinical Genomics Laboratory's saliva-based molecular test to consumers at $150 per kit.